Try our Advanced Search for more refined results
November 20, 2023
AbbVie Inc. v. Hetero USA, Inc. et al
Case Number:
1:23-cv-01332
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
November 21, 2023
AbbVie Says Rivals' Rinvoq Generics Infringe 34 Patents
AbbVie has lodged 136 patent infringement claims against Sandoz and a handful of other pharmaceutical companies, accusing them of infringing dozens of AbbVie's patents with their proposed generic versions of its blockbuster immunosuppressant Rinvoq, according to a suit filed in Delaware federal court.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login